Petco Health and Wellness heads into its late-August earnings window with short sellers quietly retreating and the borrow market loosening — a less hostile setup than the stock has worn for much of 2026.
The clearest move this week is in the cost to borrow. Lending fees have collapsed nearly 39% over seven days to just 0.43% annualised — the lowest level in the 30-day window and less than half the 0.97% peak hit on July 20. That fall in borrowing costs reflects reduced demand from new shorts, which aligns with the SI data: short interest has trimmed to 7.7% of the free float, down roughly 2% on the week and the lightest reading since late June. One month ago, SI was closer to 6.5% of float before rebuilding through July — so bears added and are now backing off into the recent price recovery. Availability is generous at 481%, meaning around five shares are available to borrow for every one already lent out, and that figure has widened further this week. This is not a squeeze setup.
Options traders are mildly more cautious than usual, though not dramatically so. The put/call ratio is running at 0.35 — just 1.3 standard deviations above its 20-day average of 0.32. That's a gentle lean toward protection rather than a full defensive tilt, and still sits far from the 52-week high of 0.75. The ORTEX short score has drifted down from 70 on July 22 to 67.5 today, consistent with slightly easing short-side pressure. Overall, the positioning picture looks cautious but not crowded — shorts trimming, borrow cheap, options calm.
The Street is a source of mild support but limited conviction. The consensus sits at hold across seven analysts, with a mean target of $3.54 against a current price of $2.84 — implying roughly 25% upside on paper. The most recent moves, both from early June, pulled in opposite directions: Citigroup trimmed its target to $3.25 while Evercore ISI nudged theirs up to $3.50. Both maintained neutral-equivalent ratings. The bull case rests on gross margin expansion — reportedly up around 120 basis points year-on-year — cost discipline from store closures, and an EPS forward recovery that ORTEX models as dramatic. The bear case centres on comparable sales still declining, vet clinic staffing headwinds, and ongoing market share losses to online pet food retailers. Factor scores capture the tension: the forward EPS revision rank is at the 95th percentile, yet the short score rank sits in just the 9th percentile, flagging that elevated SI relative to the universe continues to drag the composite view down.
Insider activity adds a note of caution. Holly May, the HR Director, sold 450,000 shares across three days in early July at prices between $2.54 and $2.55 — a total of roughly $1.15 million. That came after additional sales in April at $2.80. The transactions are flagged with modest significance scores, and May is not a C-suite principal, but the consistency of the selling pattern across multiple months is worth noting. No insider purchases have been recorded in the recent window.
Earnings history reinforces the case for hedging ahead of the August 26 print. The last two releases each produced immediate falls — down 3.2% the day after the June 3 report, and down 1.1% after the June 30 update — with five-day moves of -4.4% and -8.0% respectively. The pattern of post-earnings weakness is short but consistent.
What to watch next: whether the SI decline continues into the August 26 earnings date, or whether shorts rebuild as the print approaches — the last two cycles saw five-day declines follow the report, and that history will be front of mind for bears deciding whether to re-establish positions at $2.84.
See the live data behind this article on ORTEX.
Open WOOF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
